These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36204334)

  • 1. Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma.
    Zhou Y; Qian Y; Xiong W; Yan N; Hu B; Xiong Z; He W
    Emerg Med Int; 2022; 2022():4842370. PubMed ID: 36204334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of aparatinib and carrilizumab combined with transcatheter arterial chemoembolization in the treatment of primary hepatocellular carcinoma.
    Chen C; Duan XT; Li GY; Hao XJ; Wang WL; Shen YF; Zhang SH
    Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4135-4144. PubMed ID: 37203839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curative effect of transcatheter arterial chemoembolization combined with radiofrequency ablation in treating hepatic cell carcinoma and its effect on serum markers.
    Jiang FQ; Lu W; Yang C; Du P; Ma JP; Yang J; Xie P; Zhang Z
    Cancer Biomark; 2017 Jul; 20(1):17-22. PubMed ID: 28582848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
    Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
    Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone.
    Hassanin TM; Fouad Y; Hassnine A; Eisawy M; Farag N; Abdel Ghany W
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1255-1261. PubMed ID: 33906320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
    Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
    Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of radioactive iodine-125 microparticles in hepatocellular carcinoma with portal vein embolus.
    Meng P; Ma JP; Huang XF; Zhang KL
    World J Gastrointest Surg; 2024 Jul; 16(7):2023-2030. PubMed ID: 39087134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
    Lu B; Zhu L; Wang X; Zhong L; Cheng Y; Fan J; Yu L
    J BUON; 2019; 24(5):1979-1984. PubMed ID: 31786864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
    Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG
    BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation combined with transcatheter arterial chemoembolization for recurrent liver cancer.
    Guo JY; Zhao LL; Cai HJ; Zeng H; Mei WD
    World J Gastrointest Surg; 2024 Jun; 16(6):1756-1764. PubMed ID: 38983320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of RFA and TACE combined with postoperative cytokine-induced killer cell immunotherapy in primary hepatocellular carcinoma.
    Ji Q; Fu Y; Zhu X; Wang L; Ling C
    J BUON; 2021; 26(1):235-242. PubMed ID: 33721457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
    Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
    AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma.
    Li JX; Wu H; Huang JW; Zeng Y
    J Formos Med Assoc; 2012 Sep; 111(9):510-5. PubMed ID: 23021508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Dahuang Zhechong Pills combined with TACE on VEGF, MMP-2, TGF-β1 and immune function of patients with primary liver cancer (blood stasis and collaterals blocking type)].
    Dai CM; Jin S; Zhang JZ
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):722-729. PubMed ID: 33645040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors and model of primary liver cancer treated with transcatheter arterial chemoembolization combined with radiofrequency ablation].
    Li J; Zhu WL; Kang XX; Zheng L; Guo CY; Yu P; Xiao JC
    Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):787-791. PubMed ID: 29061025
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma.
    Zhang S; Zhao Y; He L; Bo C; An Y; Li N; Ma W; Guo Y; Guo Y; Zhang C
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101851. PubMed ID: 34923180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of TACE combined with microwave ablation on T lymphocyte subsets and prognosis in patients with liver cancer and analysis of safety.
    Wang J; Huang A; Fu P; Chen X; Zhang X; Yin Y; Zhou J
    J BUON; 2020; 25(4):1883-1889. PubMed ID: 33099928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of TACE in combination with thalidomide-mediated adjuvant therapy on the levels of VEGF and bFGF in patients with hepatocellular carcinoma.
    Tong C; Liu H; Chen R; Zhu F
    Am J Transl Res; 2021; 13(5):5575-5581. PubMed ID: 34150160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
    Shao GL; Zheng JP; Guo LW; Chen YT; Zeng H; Yao Z
    Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the comparison of postoperative liver injury caused by hepatic arterial perfusion chemotherapy combined with targeted immunotherapy with hepatic arterial chemoembolization combined with targeted immunotherapy for intermediate-and advanced-stage liver cancer].
    Li R; Li WL; Yuan GS; Pang HJ; Li Q; Hu XY; Guo YB; Chen JZ; Zang MY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1163-1168. PubMed ID: 38238949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.